PSCHvsARKGETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.75% for ARKG. PSCH is up 20.24% year-to-date (YTD) with -$10M in YTD flows. ARKG performs better with 29.47% YTD performance, and +$39M in YTD flows. Run a side-by-side ETF comparison of PSCH and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH ARKG | +5.27%-1.87% | +19.02%+27.92% | +20.24%+29.47% | +36.79%+45.31% | +19.78%+4.16% | -15.14%-54.66% |
| Flows | PSCH ARKG | +$6M+$81M | +$9M+$62M | -$10M+$39M | -$13M-$3M | -$133M-$550M | -$230M-$2.57B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH ARKG | +17.29%+44.86% | +20.07%+42.64% | +21.86%+43.40% | +22.90%+45.98% |
| Max drawdown | PSCH ARKG | -2.96%-13.14% | -15.36%-27.52% | -22.80%-51.67% | -46.32%-79.29% |
| Max drawdown duration | PSCH ARKG | 17d18d | 168d126d | 488d1058d | 1786d1814d |
Trading data
PSCH | ARKG | |
Last sale 7/27/2026 at 5:11 PM | $53.16 | $38.00 |
| Previous close 07/24/2026 | $52.95 | $37.81 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexPSCH | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/27/2026 at 5:11 PM
Live
Closed
PSCH | ARKG | |
|---|---|---|
| Last price | $53.16 | $38.00 |
| 1D performance | +0.40% | +0.50% |
| AuM | $162.74 M | $1.53 B |
| E/R | 0.29% | 0.75% |
Characteristics
PSCH | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Ark Investment |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | - |
| N° of holdings | 75 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
95.33%
Other
4.67%
ARKG
USA
86.99%
Other
13.01%
Sectors
PSCH
Healthcare
100%
Other
0%
ARKG
Healthcare
96.93%
Other
3.07%
Diversification
PSCH
Total weight of top 15 holdings out of 15
49.48%
ARKG
Total weight of top 15 holdings out of 15
74.95%
Top 15 holdings
Data as of June 30, 2026
PSCH
Molina Healthcare, Inc.
5.29%
BrightSpring Health Services, Inc.
4.82%
Krystal Biotech, Inc.
4.32%
Alkermes Plc
4.06%
Glaukos Corp.
3.75%
Corcept Therapeutics, Inc.
3.69%
Protagonist Therapeutics, Inc.
3.26%
TG Therapeutics, Inc.
3.25%
PTC Therapeutics, Inc.
3.10%
Ligand Pharmaceuticals, Inc.
2.69%
Teleflex, Inc.
2.54%
Liquidia Corp.
2.43%
Indivior Pharmaceuticals, Inc.
2.25%
Veracyte, Inc.
2.13%
RadNet, Inc.
1.90%
ARKG
Twist Bioscience Corp.
9.15%
Tempus AI, Inc.
7.64%
Absci Corp.
7.01%
10X Genomics, Inc.
7.00%
CRISPR Therapeutics AG
6.56%
Personalis, Inc.
6.19%
Beam Therapeutics, Inc.
4.34%
Guardant Health, Inc.
4.28%
Natera, Inc.
4.11%
Illumina, Inc.
3.98%
Veracyte, Inc.
3.24%
CareDx, Inc.
3.08%
Recursion Pharmaceuticals, Inc.
2.85%
Eli Lilly & Co.
2.81%
Compass Pathways Plc
2.70%
Frequently asked questions about PSCH and ARKG
How have the PSCH and ARKG ETFs performed in 2026?
As of July 24, 2026, PSCH is up 20.24% year-to-date (YTD), while ARKG has returned 29.47%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or ARKG?
Year-to-date, the PSCH ETF saw -$10M in flows, compared to +$39M for ARKG.
Which ETF is more volatile: PSCH or ARKG?
Over the past year, PSCH had a volatility of 20.07%, while ARKG experienced 42.64%.
Which ETF is bigger: PSCH or ARKG?
As of July 24, 2026, PSCH holds $162.74 M in assets under management (AUM), while ARKG manages $1.53 B.
What sectors do the PSCH and ARKG ETFs invest in?
PSCH leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the PSCH ETF and ARKG ETF?
PSCH top holdings include Molina Healthcare, Inc., BrightSpring Health Services, Inc. and Krystal Biotech, Inc.. ARKG holds in its top three: Twist Bioscience Corp., Tempus AI, Inc. and Absci Corp..
Which ETF is more diversified: PSCH or ARKG?
PSCH holds 75 securities with 49.48% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 74.95%.
Advertisement
Latest news about PSCH & ARKG
Advertisement
